Guggenheim

Lucid Q4 Earnings Preview: All Eyes On Lower EV Production, Delivery Guidance
Meta Platforms Analysts Raise Expectations After Q4 Earnings Beat: 'Growth, Profits, Buyback & Dividends All In One'
Why Snap Shares Are Trending Higher Monday
Meta Platforms Analysts Raise Expectations After Q4 Earnings Beat: 'Growth, Profits, Buyback & Dividends All In One'
Why Snap Shares Are Trending Higher Monday
Grunt Work No-More? Wokelo.AI Streamlines Due Diligence, Cut Costs, Automates 40% Of Tasks
ESPN Bet Launches In 17 States, Offers $200 In Bonus Bets: Could Competition Spell Trouble For DraftKings?

Guggenheim Recent News

4 Reasons Why This Ralph Lauren Analyst Is Bullish: 'Lower Cotton, Freight Expenses'
Shares of Ralph Lauren Corp (NYSE: RL) Monday continued their upward trajectory, after the spike on Friday last week.
5 Analysts Mixed On Meta Platforms: Post-Q2 Valuation Boost, AI Growth, But Concerns Over 2023 Share Gains, Spending
Analysts are sizing up the second quarter financial results reported by Meta Platforms (NASDAQ: META) after market close Wednesday, includin
Netflix Q2 Earnings Preview: Earnings Estimates, Analyst Predictions And Key Concerns Like The Hollywood Strike
Streaming giant Netflix Inc (NASDAQ: NFLX) is set to report second-quarter financial results after market close Wednesday, July 19.
Tesla Rallies Off Q4 Earnings: This Item 'Was All Bulls Needed To Hear,' Analyst Says
Electric vehicle giant Tesla Inc (NASDAQ: TSLA) beat analyst estimates for both revenue and earnings per share in the fourth quarter.
9 Nike Analysts On Q2 Earnings Beat, Improving Inventory Trends, China: 'Decidedly Upbeat'
Nike Inc (NYSE: NKE) shares rallied Wednesday morning after the company reported shrinking margins but said inventory levels have improved slightly on a quarterly basis.
Failure Of This Merck Study Is A 'Material Risk' But Analysts Are 'Extremely Bullish'
Merck & Co. Inc. (NYSE: MRK) seems well positioned to surpass 2023 consensus estimates, driven by margin potential, according to Guggenheim. The Analyst: Seamus Fernandez upgraded the rating for Merck from Neutral to Buy, while establishing a price target of $104.
5 Kohl's Analysts On Bloated Inventory, Guidance Cut: 'Fundamentals Are Likely To Get Worse'
Kohl's Corporation (NYSE: KSS) shares are down 4% on Friday after the company cut its guidance and said inflation is eating into its sales growth.
Why This Teladoc Health Analyst Expects 25%-30% Revenue Growth
Teladoc Health Inc (NYSE: TDOC) is a market leader in digital services, and the breadth of its services is unmatched, according to Guggenheim. The Teladoc Health Analyst: Sandy Draper initiated coverage of Teladoc Health with a Buy rating and $96 price target.
Pinterest's Stock Continues On Downward Spiral: What's Next?
Pinterest Inc (NYSE: PINS) shares traded lower Tuesday following a downgrade from Guggenheim. Analyst Michael Morris downgraded the stock from a Buy to a Neutral rating and lowered the price target from $46 to $39. This pushed Pinterest further below a technical channel it traded in.
Guggenheim CIO Scott Minerd Regrets Not Investing In Shiba Inu: 'I Wish I'd Invested $100,000'
Scott Minerd, the chief investment officer at Guggenheim Partners, revealed that he regrets missing out on the Shiba Inu (CRYPTO: SHIB) rally.
Can DraftKings Keep Its Competitive Edge While Growing
The large online sports betting and iGaming markets has an analyst impressed with the opportunity for DraftKings to keep its competitive advantage and grow with the market.
Fintech Focus For March 9, 2021
Why Guggenheim Is Bullish On Passage Bio
Passage Bio Inc (NASDAQ: PASG) is leveraging the UPenn Gene Therapy Program to access compelling translational research and develop a range of differentiated adeno-associated virus gene therapies for rare central nervous system disorders, according to Guggenheim.
Will Bitcoin 'Rise 50% And Possibly Double' In 2021? These Pros Think So
Bitcoin gained another 13.1% in the past 24 hours and was trading above $23,500 for the first time in history on Thursday morning. The bitcoin rally has triggered a wave of new bullish bitcoin targets on Wall Street, and deVere Group is now calling for at least 50% more upside in 2021.
Fintech Focus For November 30, 2020
Quote To Start The Day: Before you judge a man, walk a mile in his shoes. After that who cares?... He’s a mile away and you’ve got his shoes!
Guggenheim Predicts 'Tough Road' Ahead For Comcast, Downgrades Stock
Comcast Corporation (NASDAQ: CMCSA) faces a "tough road" ahead as the COVID-19 pandemic is likely to impact each business unit, according to Guggenheim.
3 Reasons For Guggenheim's PayPal Upgrade
Guggenheim Incrementally Bullish On Dunkin' Brands
Guggenheim Takes On Auto Suppliers, Bullish On Aptiv And Gentex
Guggenheim Upgrades Snap, Says Long-Term Revenue Potential Is Underappreciated
Roku's Rough Week: A Constructive Pullback For The Stock?
Bed Bath & Beyond Plunges To New Lows After Earnings: Here's What The Street Is Saying
Wix Reports Q1 Results: 4 Sell-Side Takes